1014825

Amgen, Inc. — FEI 2026154

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 19, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Thousand Oaks, CA (United States)

Additional Details

Sponsor, Contract Research Organization